NATIONAL

‘Pharma Bro’ Firm Reaches $40M Settlement In Gouging Case

0
FILE- Pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington, on Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Vyera Pharmaceuticals, a company once owned by Shkreli, will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug. The Federal Trade Commission announced the settlement Tuesday, Dec. 7, 2021. (AP Photo/Susan Walsh, File)

(AP) — A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug. The Federal Trade Commission announced the settlement Tuesday. The FTC and seven states sued Vyera Pharmaceuticals for allegedly gouging consumers and blocking competitors from creating cheaper generic versions of the drug Daraprim after obtaining exclusive rights to it in 2015. Vyera was owned by Martin Shkreli. The drug treats a potentially deadly parasitic infection. Shkreli currently is serving seven years for hedge fund securities fraud.

 

Fred Cruz

Australia Joins US In Diplomatic Boycott Of Beijing Olympics

Previous article

Giant Christmas Tree Outside Fox News Headquarters Set Afire

Next article

You may also like

More in NATIONAL